Cargando…

Effectiveness of Amlodipine in the Control of 24-Hour Blood Pressure in Mild-to-Moderate Essential Hypertension: A Prospective, Multicenter, Observational Real-World Study from India

Background Calcium-channel blockers (CCB) are a mainstay in the management of hypertension (HTN), and amlodipine is the preferred CCB due to its longer half-life and better safety. Patients and methods This practice-based, observational, real-world evidence study assessed the 24-hour ambulatory bloo...

Descripción completa

Detalles Bibliográficos
Autores principales:	D, Prabhakar, Guha, Santanu, Rathod, Rahul, Gaurav, Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225746/ https://www.ncbi.nlm.nih.gov/pubmed/37255900 http://dx.doi.org/10.7759/cureus.38272

Ejemplares similares

Amlodipine-Induced Liver Injury
por: Yet Kwong Horman, Julian, et al.
Publicado: (2022)

Amlodipine/Valsartan (Avsar®): Efficacy in Hypertensive Patients - A Real World Observational Study (ALERT)
por: Khan, Khalid M, et al.
Publicado: (2020)

Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial
por: Dash, Ashish, et al.
Publicado: (2023)

Acute Multi-Organ Toxicity During 24-Hour Dosing of Intravenous Amiodarone: A Case Report
por: Liwag, Terrin, et al.
Publicado: (2022)

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
por: Lacourcière, Y, et al.
Publicado: (2011)

24-Hour Holter Monitoring for Identification of an Ideal Ventricular Rate for a Better Quality of Life in Atrial Fibrillation Patients
por: Sanip, Zulkefli, et al.
Publicado: (2023)

Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension
por: Wang, Xiao-ou, et al.
Publicado: (2019)

Incidence of Cardiac Arrhythmias in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention and Associated Outcomes During the First 24 Hours
por: Shah, Jehangir A, et al.
Publicado: (2021)

Diagnostic Comparability and Interchangeability Between Daytime Ambulatory Blood Pressure Monitoring and 24-Hour Ambulatory Blood Pressure Monitoring in Detecting Masked Hypertension
por: Kinsara, Abdulhalim J, et al.
Publicado: (2020)

24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
por: Lee, Hae-Young, et al.
Publicado: (2017)

Posterior Reversible Encephalopathy Syndrome Onset Within 24 Hours Following Moderna mRNA Booster COVID-19 Vaccination: Vaccine Adverse Event Vs. Hypertension?
por: McCullough, Jocelyn, et al.
Publicado: (2022)

Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
por: Adake, Prabhakar, et al.
Publicado: (2015)

Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: Comparison of their efficacy and effects on electrolytes
por: Nwachukwu, Daniel C, et al.
Publicado: (2017)

Five Hours of Resuscitation With 150 Electrical Shocks and Complete Recovery
por: Tabachnikov, Vsevolod, et al.
Publicado: (2021)

Losartan/Hydrochlorothiazide Fixed Combination Versus Amlodipine Monotherapy in Korean Patients With Mild to Moderate Hypertension
por: Chung, Jin-Wook, et al.
Publicado: (2009)

Three Hours Ambulatory Blood Pressure: A Surrogate for Daytime Ambulatory Blood Pressure Assessment in the Pakistani Population
por: Shahab, Hunaina, et al.
Publicado: (2021)

Effect of "no added salt diet" on blood pressure control and 24 hour urinary sodium excretion in mild to moderate hypertension
por: Kojuri, Javad, et al.
Publicado: (2007)

Managing sleep and wakefulness in a 24-hour world
por: Coveney, Catherine M
Publicado: (2014)

Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
por: Joshi, Shashank, et al.
Publicado: (2022)

Reduced blood pressure variability in AS COT -BPLA trial favours use of amlodipine/perindopril combination to reduce stroke risk
por: Aalbers, J
Publicado: (2010)

A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients
por: Umeh, Chukwuemeka, et al.
Publicado: (2022)

Essential Thrombocythemia in a Nonagenarian Presenting With Acute Myocardial Infarction
por: Tanabe, Junya, et al.
Publicado: (2020)

A Young Adult With Essential Thrombocythemia Presenting as Myocardial Infarction
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}
por: Xu, Mengzhuo, et al.
Publicado: (2023)

The Role of Prognostic Nutrition Index in Predicting Hospitalization of Patients With Heart Failure With Mildly Reduced Ejection Fraction
por: Yurdam, Ferhat S, et al.
Publicado: (2022)

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine
por: Dalal, Jamshed, et al.
Publicado: (2022)

Quality and Reliability of YouTube Videos on Myocardial Infarction: A Cross-Sectional Study
por: Holge, Shubham, et al.
Publicado: (2023)

Acute ST-segment Elevation Myocardial Infarction as the First Manifestation of Essential Thrombocytosis
por: Sharma, Purva, et al.
Publicado: (2019)

A Myocardial Infarction Following a Mild Case of COVID-19 in a 26-Year-Old Male
por: Wolsky, Ryan M, et al.
Publicado: (2022)

The Discovery of an Intracardiac Thrombus Following a Mild COVID-19 Infection: A Case Report and Review of Literature
por: Bhandari, Jenish, et al.
Publicado: (2023)

Development and Validation of Two Prediction Models for 72-Hour Mortality in High-Risk Trauma Patients Using a Benchmark Dataset: A Comparative Study of Logistic Regression and Neural Networks Models
por: Islam, Mehmet Muzaffer
Publicado: (2023)

A Case of Chagas Cardiomyopathy in Western Virginia: Worlds Away?
por: Vattikonda, Kiriti, et al.
Publicado: (2023)

Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review
por: Al Rawahi, Mohamed N, et al.
Publicado: (2023)

Impact of Asthma Phenotypes on Myocardial Performance and Pulmonary Hypertension in Children and Adolescents With Moderate to Severe Persistent Asthma
por: Kundavaram, Rajkumar, et al.
Publicado: (2023)

ST-Elevation Myocardial Infarction as a Late Complication of Mild Coronavirus Disease 2019 Infection: A Case Report
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
por: Prabhakar Bhat, Sangeeta, et al.
Publicado: (2021)

A Rare Case of Pseudo-atrial Flutter Waves in a Patient with Essential Tremor
por: Papanastasiou, Christos A, et al.
Publicado: (2019)

Hypertension as an Independent Risk Factor for In-Patient Mortality in Hospitalized COVID-19 Patients: A Multicenter Study
por: Mirza, Hasan, et al.
Publicado: (2022)

The Pattern of Valvular Heart Diseases in India During Pregnancy and Its Outcomes
por: Kumari, Anupama, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1oc1ojsitpdr8sqqt81pcp46le